Keshari Sankalp, Kumar Navneet, Varghese Ashish, Pratap Singh Shivendra, Yadav Rohini, Singh Niranjan Arvind
Department of ENT & HNS, MLN Medical College, Prayagraj, India.
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4126-4132. doi: 10.1007/s12070-024-04799-1. Epub 2024 Jun 19.
Chronic rhinosinusitis (CRS) is one of the most prevalent conditions in medicine causing a considerable amount of healthcare expenditure. This study was performed to clinically diagnose chronic rhinosinusitis with or without polyps and to measure the intensity of patients' symptoms and treatment outcomes. This was a prospective cohort study, which included 70 patients diagnosed with CRS according to the EPOS-2012 and were given SNOT-22 questionnaire preoperatively, which was repeated on 1st, 4 and 12th weeks post-op to determine the treatment outcome. Patients were divided into three groups according to their predominant histopathological features and the treatment outcomes were assessed based on SNOT-22 scoring system. According to our study, ESS effectively raised the quality of life for CRS patients, and one week after surgery, there was a significant improvement in total symptoms (from 49.01 ± 14.83 to 21.91 ± 8.88). it was noted that there was a decrease in SNOT-22 scores at various intervals from baseline to week 12. The four subscales of the SNOT-22 test (rhinological symptoms, ear and facial symptoms, sleep function, and psychological difficulties) showed significant improvements in quality of life across all groups, and this relationship extended beyond the relationship with rhinological symptoms. These improvements were statistically significant after three months of post operative medical therapy. SNOT-22 is determined to be reliable and convenient to use. After ESS, all of the symptoms in our study showed a drop in SNOT-22 scores from week 1 to week 12, indicating an improvement in overall symptoms. Therefore, it can be used to monitor the success of surgical intervention in addition to medicinal therapy.
慢性鼻-鼻窦炎(CRS)是医学上最常见的疾病之一,造成了相当可观的医疗支出。本研究旨在对伴或不伴鼻息肉的慢性鼻-鼻窦炎进行临床诊断,并测量患者症状的严重程度及治疗效果。这是一项前瞻性队列研究,纳入了70例根据2012版欧洲鼻窦炎和鼻息肉诊疗指南(EPOS-2012)诊断为CRS的患者,术前给予鼻窦症状测试-22(SNOT-22)问卷,并在术后第1周、第4周和第12周重复进行以确定治疗效果。根据主要组织病理学特征将患者分为三组,并基于SNOT-22评分系统评估治疗效果。根据我们的研究,鼻内镜鼻窦手术(ESS)有效提高了CRS患者的生活质量,术后1周,总症状有显著改善(从49.01±14.83降至21.91±8.88)。值得注意的是,从基线到第12周的不同时间间隔,SNOT-22评分均有下降。SNOT-22测试的四个子量表(鼻科症状、耳和面部症状、睡眠功能及心理障碍)在所有组中均显示生活质量有显著改善,且这种关系不仅限于与鼻科症状的关系。术后药物治疗三个月后,这些改善具有统计学意义。SNOT-22被确定为使用可靠且方便。ESS术后,我们研究中的所有症状在第1周和第12周之间SNOT-22评分均下降,表明总体症状有所改善。因此,除药物治疗外,它还可用于监测手术干预的成功与否。